Doesn't reveal much, but figured I'd share the link:http://www.hotstocked.com/article/2544/omeros-corp-nasdaq-omer-draws-back-the-high.html
Easy come, easy go I guess. Thinly traded & easily manipulated. Need some real news, e.g., P3 results, out-licensing deal of GPCRs, etc.
I agree. Unfortunately medical reseach is a slow process. Also earnings news is irrelevant, about the only metric I watch is cash burn.